Giehrl W - Search Results

1

Brain natriuretic peptide and exercise capacity in lung fibrosis and pulmonary hypertension.

Leuchte HH, Neurohr C, Baumgartner R, Holzapfel M, Giehrl W, Vogeser M, Behr J. Leuchte HH, et al. Among authors: giehrl w. Am J Respir Crit Care Med. 2004 Aug 15;170(4):360-5. doi: 10.1164/rccm.200308-1142OC. Epub 2004 Apr 15. Am J Respir Crit Care Med. 2004. PMID: 15087298 Clinical Trial.

2

Retroinfusion-supported stenting in high-risk patients for percutaneous intervention and bypass surgery: results of the prospective randomized myoprotect I study.

Pohl T, Giehrl W, Reichart B, Kupatt C, Raake P, Paul S, Reichenspurner H, Steinbeck G, Boekstegers P. Pohl T, et al. Among authors: giehrl w. Catheter Cardiovasc Interv. 2004 Jul;62(3):323-30. doi: 10.1002/ccd.20060. Catheter Cardiovasc Interv. 2004. PMID: 15224298 Clinical Trial.

3

Targeting of dobutamine to ischemic myocardium without systemic effects by selective suction and pressure-regulated retroinfusion.

von Degenfeld G, Giehrl W, Boekstegers P. von Degenfeld G, et al. Among authors: giehrl w. Cardiovasc Res. 1997 Aug;35(2):233-40. doi: 10.1016/s0008-6363(97)00126-0. Cardiovasc Res. 1997. PMID: 9349386

4

Selective suction and pressure-regulated retroinfusion: an effective and safe approach to retrograde protection against myocardial ischemia in patients undergoing normal and high risk percutaneous transluminal coronary angioplasty.

Boekstegers P, Giehrl W, von Degenfeld G, Steinbeck G. Boekstegers P, et al. Among authors: giehrl w. J Am Coll Cardiol. 1998 Jun;31(7):1525-33. doi: 10.1016/s0735-1097(98)00135-1. J Am Coll Cardiol. 1998. PMID: 9626830 Free article. Clinical Trial.

5

Subchronic exposure of cardiomyocytes to low concentrations of tumor necrosis factor alpha attenuates the positive inotropic response not only to catecholamines but also to cardiac glycosides and high calcium concentrations.

Boekstegers P, Kainz I, Giehrl W, Peter W, Werdan K. Boekstegers P, et al. Among authors: giehrl w. Mol Cell Biochem. 1996 Mar 23;156(2):135-43. doi: 10.1007/BF00426336. Mol Cell Biochem. 1996. PMID: 9095470

6

Myocardial gene transfer by selective pressure-regulated retroinfusion of coronary veins.

Boekstegers P, von Degenfeld G, Giehrl W, Heinrich D, Hullin R, Kupatt C, Steinbeck G, Baretton G, Middeler G, Katus H, Franz WM. Boekstegers P, et al. Among authors: giehrl w. Gene Ther. 2000 Feb;7(3):232-40. doi: 10.1038/sj.gt.3301079. Gene Ther. 2000. PMID: 10694800

7

Selective pressure-regulated retroinfusion of coronary veins as an alternative access of ischemic myocardium: implications for myocardial protection, myocardial gene transfer and angiogenesis.

Boekstegers P, von Degenfeld G, Giehrl W, Kupatt C, Franz W, Steinbeck G. Boekstegers P, et al. Among authors: giehrl w. Z Kardiol. 2000;89 Suppl 9:IX/109-12. doi: 10.1007/s003920070013. Z Kardiol. 2000. PMID: 11151777

8

Comparison of Pura-Vario and Palmaz-Schatz stents following implantation using normal and high pressure in pigs: immediate and late results assessed by 3-dimensional IVUS.

von Degenfeld G, Heinrich D, Giehrl W, Boekstegers P. von Degenfeld G, et al. Among authors: giehrl w. Z Kardiol. 1999 Nov;88(11):906-13. doi: 10.1007/s003920050368. Z Kardiol. 1999. PMID: 10643058

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

8 results

Search Page

Filters